CIP 330
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Pediatrics

Type of Study:
Pivotal single arm study for CGM

Study Length:
approximately 90 days

Target Age/Sex:
ages 2 - 17, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Staus: Closed

Description:

This study is to demonstrate the performance of the disposable sensor of the updated Continuous Glucose Monitoring (CGM) system in pediatric patients.

This Study is Closed.